Arcturus Therapeutics Holdings (ARCT) Revenue: 2018-2025
Historic Revenue for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Sep 2025 value amounting to $17.2 million.
- Arcturus Therapeutics Holdings' Revenue fell 58.84% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.6 million, marking a year-over-year decrease of 39.15%. This contributed to the annual value of $152.3 million for FY2024, which is 8.69% down from last year.
- Per Arcturus Therapeutics Holdings' latest filing, its Revenue stood at $17.2 million for Q3 2025, which was down 39.40% from $28.3 million recorded in Q2 2025.
- Arcturus Therapeutics Holdings' 5-year Revenue high stood at $160.3 million for Q4 2022, and its period low was $2.0 million during Q2 2021.
- Over the past 3 years, Arcturus Therapeutics Holdings' median Revenue value was $30.9 million (recorded in 2023), while the average stood at $35.8 million.
- In the last 5 years, Arcturus Therapeutics Holdings' Revenue skyrocketed by 2,666.53% in 2022 and then crashed by 80.75% in 2023.
- Arcturus Therapeutics Holdings' Revenue (Quarterly) stood at $5.8 million in 2021, then skyrocketed by 2,666.53% to $160.3 million in 2022, then crashed by 80.75% to $30.9 million in 2023, then decreased by 26.22% to $22.8 million in 2024, then crashed by 58.84% to $17.2 million in 2025.
- Its Revenue stands at $17.2 million for Q3 2025, versus $28.3 million for Q2 2025 and $29.4 million for Q1 2025.